Similarly, long‐term use of statins that inhibit HMGCR is associated with a higher incidence of T2D (Corrao et al., 2014; Ridker et al., 2012; Sattar et al., 2010; Swerdlow et al., 2015). This evidence concerns the gene HMGCR and type 2 diabetes mellitus.